CH Med: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
CH Med
Largest movements
- Cash +€133,566
up €133,566 (+503.9%), from €26,505 to €160,071
mainly Net result for the year (+€105,584) and Tax, wage and social debts (+€30,103)
- Receivables within one year +€2,225
new in 2025: €2,225
- Profit (loss) carried forward +€105,584
up €105,584 (+241.5%), from €43,727 to €149,311
- Tax, wage and social debts +€30,103
up €30,103 (+270.2%), from €11,142 to €41,245
- Gross operating margin +€80,936
up €80,936 (+147.3%), from €54,952 to €135,888
- Taxes +€18,977
up €18,977 (+170.3%), from €11,142 to €30,120
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €58,318 | €194,738 | +€136,420 | +233.9% |
| Current assets | 29/58 | €58,318 | €194,738 | +€136,420 | +233.9% |
| Amounts receivable within one year | 40/41 | - | €2,225 | +€2,225 | |
| Other amounts receivable | 41 | - | €2,225 | +€2,225 | |
| Cash at bank and in hand | 54/58 | €26,505 | €160,071 | +€133,566 | +503.9% |
| Deferred charges and accrued income | 490/1 | €31,813 | €32,443 | +€630 | +2.0% |
| Total equity and liabilities | 10/49 | €58,318 | €194,738 | +€136,420 | +233.9% |
| Equity | 10/15 | €46,227 | €151,811 | +€105,584 | +228.4% |
| Contributions | 10/11 | €2,500 | €2,500 | = | 0.0% |
| Profit (loss) carried forward | 14 | €43,727 | €149,311 | +€105,584 | +241.5% |
| Amounts payable | 17/49 | €12,091 | €42,928 | +€30,837 | +255.0% |
| Amounts payable within one year | 42/48 | €11,964 | €42,319 | +€30,355 | +253.7% |
| Trade debts | 44 | - | €1,074 | +€1,074 | |
| Suppliers | 440/4 | - | €1,074 | +€1,074 | |
| Taxes, remuneration and social security | 45 | €11,142 | €41,245 | +€30,103 | +270.2% |
| Taxes | 450/3 | €11,142 | €41,245 | +€30,103 | +270.2% |
| Other amounts payable | 47/48 | €822 | - | -€822 | |
| Accrued charges and deferred income | 492/3 | €127 | €608 | +€481 | +378.9% |
| Other operating charges | 640/8 | €50 | €50 | = | 0.0% |
| Gross operating margin | 9900 | €54,952 | €135,888 | +€80,936 | +147.3% |
| Operating profit (loss) | 9901 | €54,902 | €135,838 | +€80,936 | +147.4% |
| Financial income | 75/76B | - | €56 | +€56 | |
| Recurring financial income | 75 | - | €56 | +€56 | |
| Financial charges | 65/66B | €33 | €190 | +€157 | +478.8% |
| Recurring financial charges | 65 | €33 | €190 | +€157 | +478.8% |
| Profit (loss) for the period before taxes | 9903 | €54,869 | €135,703 | +€80,834 | +147.3% |
| Income taxes | 67/77 | €11,142 | €30,120 | +€18,977 | +170.3% |
| Profit (loss) for the period | 9904 | €43,727 | €105,584 | +€61,857 | +141.5% |
| Profit (loss) for the period to be appropriated | 9905 | €43,727 | €105,584 | +€61,857 | +141.5% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 11 October 2026 via checked.be.